After 2-week run-in with twice-daily BUD 160 mg via pressurized metered dose inhaler (pMDI), patients received twice-daily BUD/FM pMDI 320/9 mg, BUD pMDI 320 mg, FM 9 mg via drypowder inhaler, or PBO.